Reverdia, a joint venture between DSM and Roquette Frères, has appointed Marcel Lubben as its new president. Lubben replaces General Manager Will van den Tweel, who led the start-up of Reverdia. Van den Tweel drove the joint collaboration between Roquette and DSM on Biosuccinium and was one of the founders of DSM's innovation initiatives into industrial biotechnology.

Lubben joined DSM in 1994. He held positions in Research, Business Development and Marketing & Sales in DSM Pharma Chemicals and DSM Biologics before transitioning into the industrial biotechnology sector. In 2009, he was appointed Managing Director Licensing for DSM and became Managing Director Venturing & Licensing in 2011. In 2012 he became vice president Bio-based Chemicals & Materials, and he served as a member of the Reverdia board from mid-2012 until the end of 2013.